Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone [Corrigendum]

David B Price; William Henley; José Eduardo Delfini Cançado; Leonardo M Fabbri; Huib AM Kerstjens; Alberto Papi; Nicolas Roche; Elif Şen; Dave Singh; Claus F Vogelmeier; Sara Barille; Elena Nudo; Victoria Carter; Derek Skinner; Rebecca Vella; George Georges

doi:10.2147/COPD.S363875

open access to scientific and medical research

Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 17

Corrigendum

Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone [Corrigendum]

Total article views		HTML views	PDF downloads	Totals
3,833	Dovepress*	3,757+	291	4,048
	PubMed Central*	76	25	101
	Totals	3,833	316	4,149
*Since 7 March 2022

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.